{
    "clinical_study": {
        "@rank": "126223", 
        "acronym": "MICROGUT", 
        "arm_group": {
            "arm_group_label": "HIV-1 patients"
        }, 
        "biospec_descr": {
            "textblock": "Stool sample"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The bacterial diversity of HIV patients digestive microbiota seropositive  is poorly\n      understood, it remains to be defined."
        }, 
        "brief_title": "Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "HIV-1 Infection", 
        "condition_browse": {
            "mesh_term": [
                "HIV Seropositivity", 
                "HIV Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient aged 18 or more.\n\n          -  Patients with a confirmed diagnosis of HIV infection 1.\n\n          -  Patient who signed an informed consent form.\n\n          -  Patient affiliated or beneficiary of a social security system.\n\n        Exclusion Criteria:\n\n          -  Patient known to be suffering from inflammatory bowel disease (Crohn's disease or\n             ulcerative colitis).\n\n          -  Patient HIV-2 or HIV-1/HIV-2 co-infected\n\n          -  Patient participating in another research.\n\n          -  Pregnant women, parturient or lactating person under guardianship, or deprived of\n             liberty by a judicial or administrative decision."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "HIV-1 seropositive patients of hospital"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02116374", 
            "org_study_id": "ANRS EP55 MICROGUT", 
            "secondary_id": "2014-A00216-41"
        }, 
        "intervention": {
            "arm_group_label": "HIV-1 patients", 
            "intervention_name": "Physiopathology study", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 15, 2014", 
        "location": {
            "contact": {
                "email": "jeanchristophe.lagier@ap-hm.fr", 
                "last_name": "Jean Christophe Lagier, MD-PHD"
            }, 
            "facility": {
                "address": {
                    "city": "Marseille", 
                    "country": "France", 
                    "zip": "13005"
                }, 
                "name": "IHU M\u00e9diterran\u00e9e Infection; H\u00f4pital Nord, AP-HM"
            }, 
            "investigator": {
                "last_name": "Jean Christophe Lagier, MD-PHD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Correlation Between Microbiota Biodiversity of HIV Seropositive Patients With Their Clinical and Immunological Status (ANRS EP 55 MICROGUT).", 
        "overall_contact": {
            "email": "didier.raoult@gmail.com", 
            "last_name": "Didier Raoult, MD-PHD"
        }, 
        "overall_official": {
            "affiliation": "IHU M\u00e9diterran\u00e9e infection", 
            "last_name": "Didier Raoult, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion and type of OTU (Operational Taxonomic Unit) assigned to the rank of phylum genus and species of bacteria in the intestinal microbiota of HIV-1 seropositive patients.", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02116374"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Proportion and OTU types in the gastrointestinal microbiota of HIV-1 seropositive patients compared to the general population", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Proportion and OTU types in the gastrointestinal microbiota of HIV-1 seropositive patients based on CD4, viral load, the Elite controller status, antiretroviral and antibiotic treatment and the existence of invasive bacterial infections.", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Proportion and OTU types in the gastrointestinal microbiota of HIV-1 seropositive patients based on inflammation parameters (IL-6, TNF-a, IP-10), CRPus, CD14 and integrity of the epithelial barrier (I-FABP).", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Transcriptomic analysis in the groups that present differences in the microbiota and analysis of lymphocyte populations Th17 and Treg.", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }
        ], 
        "source": "French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}